These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 24833923)

  • 1. Effects of irbesartan on serum uric acid levels in patients with hypertension and diabetes.
    Nakamura M; Sasai N; Hisatome I; Ichida K
    Clin Pharmacol; 2014; 6():79-86. PubMed ID: 24833923
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elevated Serum Uric Acid Is Associated With Greater Risk for Hypertension and Diabetic Kidney Diseases in Obese Adolescents With Type 2 Diabetes: An Observational Analysis From the Treatment Options for Type 2 Diabetes in Adolescents and Youth (TODAY) Study.
    Bjornstad P; Laffel L; Lynch J; El Ghormli L; Weinstock RS; Tollefsen SE; Nadeau KJ;
    Diabetes Care; 2019 Jun; 42(6):1120-1128. PubMed ID: 30967435
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interactive association of baseline and changes in serum uric acid on renal dysfunction among community-dwelling persons.
    Kawamoto R; Ninomiya D; Akase T; Kikuchi A; Kumagi T
    J Clin Lab Anal; 2020 May; 34(5):e23166. PubMed ID: 31880007
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of diabetic nephropathy with angiotensin II receptor antagonist.
    Lewis EJ; Lewis JB
    Clin Exp Nephrol; 2003 Mar; 7(1):1-8. PubMed ID: 14586737
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An initial reduction in serum uric acid during angiotensin receptor blocker treatment is associated with cardiovascular protection: a post-hoc analysis of the RENAAL and IDNT trials.
    Smink PA; Bakker SJ; Laverman GD; Berl T; Cooper ME; de Zeeuw D; Lambers Heerspink HJ
    J Hypertens; 2012 May; 30(5):1022-8. PubMed ID: 22388234
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of febuxostat to prevent a further reduction in renal function of patients with hyperuricemia who have never had gout and are complicated by chronic kidney disease stage 3: study protocol for a multicenter randomized controlled study.
    Hosoya T; Kimura K; Itoh S; Inaba M; Uchida S; Tomino Y; Makino H; Matsuo S; Yamamoto T; Ohno I; Shibagaki Y; Iimuro S; Imai N; Kuwabara M; Hayakawa H
    Trials; 2014 Jan; 15():26. PubMed ID: 24433285
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alteration of normal level of serum urate may contribute to decrease in estimated glomerular filtration rate decline in healthy Japanese men.
    Kuma A; Mafune K; Uchino B; Ochiai Y; Enta K; Kato A
    Ren Fail; 2021 Dec; 43(1):1408-1415. PubMed ID: 34633265
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of serum uric acid on renal function and cardiovascular events in hypertensive patients treated with losartan.
    Ito S; Naritomi H; Ogihara T; Shimada K; Shimamoto K; Tanaka H; Yoshiike N
    Hypertens Res; 2012 Aug; 35(8):867-73. PubMed ID: 22573200
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Elevated Serum Uric Acid Level Predicts Rapid Decline in Kidney Function.
    Kuwabara M; Bjornstad P; Hisatome I; Niwa K; Roncal-Jimenez CA; Andres-Hernando A; Jensen T; Milagres T; Sato Y; Garcia G; Ohno M; Lanaspa MA; Johnson RJ
    Am J Nephrol; 2017; 45(4):330-337. PubMed ID: 28285309
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of Uric Acid on Hypertension Occurrence and Target Organ Damage: Insights From the STANISLAS Cohort With a 20-Year Follow-up.
    Kanbay M; Girerd N; Machu JL; Bozec E; Duarte K; Boivin JM; Wagner S; Ferreira JP; Zannad F; Rossignol P
    Am J Hypertens; 2020 Sep; 33(9):869-878. PubMed ID: 32267470
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of a reduction in uric acid on renal outcomes during losartan treatment: a post hoc analysis of the reduction of endpoints in non-insulin-dependent diabetes mellitus with the Angiotensin II Antagonist Losartan Trial.
    Miao Y; Ottenbros SA; Laverman GD; Brenner BM; Cooper ME; Parving HH; Grobbee DE; Shahinfar S; de Zeeuw D; Lambers Heerspink HJ
    Hypertension; 2011 Jul; 58(1):2-7. PubMed ID: 21632472
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of combined antihypertensive therapy with losartan/hydrochlorothiazide on uric acid metabolism.
    Hosoya T; Kuriyama S; Yoshizawa T; Kobayashi A; Otsuka Y; Ohno I
    Intern Med; 2012; 51(18):2509-14. PubMed ID: 22989819
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hyperuricemia Predicts an Early Decline in Renal Function among Older People: A Community-Based Cohort Study.
    Tseng WC; Chen YT; Lin YP; Ou SM; Yang CY; Lin CH; Tarng DC;
    Sci Rep; 2019 Jan; 9(1):980. PubMed ID: 30700753
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The therapeutic advantage of combination antihypertensive drug therapy using amlodipine and irbesartan in hypertensive patients: Analysis of the post-marketing survey data from PARTNER (Practical combination therapy of Amlodin and angiotensin II Receptor blocker; safety and efficacy in patients with hypertension) study.
    Ishimitsu T; Fukuda H; Uchida M; Ishibashi K; Sato F; Nukui K; Nagao M
    Clin Exp Hypertens; 2015; 37(7):542-50. PubMed ID: 25978131
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of hyperuricemia on the blood pressure response to antihypertensive agents in hospitalized elderly patients.
    Zhu P; Lin F; Lin C; Hong D; Lin K; Chen H
    J Cardiovasc Med (Hagerstown); 2012 Nov; 13(11):741-6. PubMed ID: 22964647
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum uric acid and its association with hypertension, early nephropathy and chronic kidney disease in type 2 diabetic patients.
    Fouad M; Fathy H; Zidan A
    J Bras Nefrol; 2016 Dec; 38(4):403-410. PubMed ID: 28001185
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Concentration-dependent inhibitory effect of irbesartan on renal uric acid transporters.
    Nakamura M; Anzai N; Jutabha P; Sato H; Sakurai H; Ichida K
    J Pharmacol Sci; 2010; 114(1):115-8. PubMed ID: 20736511
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of serum uric acid levels with the incident of kidney disease and rapid eGFR decline in Chinese individuals with eGFR > 60 mL/min/1.73 m
    Zhou F; Yu G; Wang G; Liu Y; Zhang L; Wang W; Chen N
    Clin Exp Nephrol; 2019 Jul; 23(7):871-879. PubMed ID: 30734168
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum uric acid levels and decreased estimated glomerular filtration rate in patients with type 2 diabetes: A cohort study and meta-analysis.
    Wang J; Yu Y; Li X; Li D; Xu C; Yuan J; Wei S; Li X; Yang K; Zheng D; Tang Y; Yang H; Wu T; He M
    Diabetes Metab Res Rev; 2018 Oct; 34(7):e3046. PubMed ID: 30003679
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of allopurinol on the glomerular filtration rate of children with chronic kidney disease.
    Ghane Sharbaf F; Assadi F
    Pediatr Nephrol; 2018 Aug; 33(8):1405-1409. PubMed ID: 29549464
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.